(E)‐SIS3 suppressed osteosarcoma progression via promoting cell apoptosis, arresting cell cycle, and regulating the tumor immune microenvironment
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
(E)‐SIS3 suppressed osteosarcoma progression via promoting cell apoptosis, arresting cell cycle, and regulating the tumor immune microenvironment
Authors
Keywords
-
Journal
DRUG DEVELOPMENT RESEARCH
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2023-10-03
DOI
10.1002/ddr.22120
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Ubiquitin like protein FAT10 repressed cardiac fibrosis after myocardial ischemic via mediating degradation of Smad3 dependent on FAT10-proteasome system
- (2023) Chen Chen et al. International Journal of Biological Sciences
- SMAD3 promotes expression and activity of the androgen receptor in prostate cancer
- (2023) Hee-Young Jeon et al. NUCLEIC ACIDS RESEARCH
- Single-cell RNA datasets and bulk RNA datasets analysis demonstrated C1Q+ tumor-associated macrophage as a major and antitumor immune cell population in osteosarcoma
- (2023) Jihao Tu et al. Frontiers in Immunology
- Anti-Invasive and Anti-Migratory Effects of Ononin on Human Osteosarcoma Cells by Limiting the MMP2/9 and EGFR-Erk1/2 Pathway
- (2023) Guowei Gong et al. Cancers
- IOX-1 suppresses metastasis of osteosarcoma by upregulating histone H3 lysine trimethylation
- (2023) Sunny Li-Yun Chang et al. BIOCHEMICAL PHARMACOLOGY
- Advances in Osteosarcoma
- (2023) Isidora Panez-Toro et al. Current Osteoporosis Reports
- LncRNA CASC15, MiR-23b Cluster and SMAD3 form a Novel Positive Feedback Loop to promote Epithelial-Mesenchymal Transition and Metastasis in Ovarian Cancer
- (2022) Hui Lin et al. International Journal of Biological Sciences
- Self-carried nanodrug (SCND-SIS3): A targeted therapy for lung cancer with superior biocompatibility and immune boosting effects
- (2022) Guang-Yu Lian et al. BIOMATERIALS
- Sestrin2 remedies podocyte injury via orchestrating TSP-1/TGF-β1/Smad3 axis in diabetic kidney disease
- (2022) Shan Song et al. Cell Death & Disease
- Breast cancer cell-derived extracellular vesicles promote CD8+ T cell exhaustion via TGF-β type II receptor signaling
- (2022) Feng Xie et al. Nature Communications
- TISCH2: expanded datasets and new tools for single-cell transcriptome analyses of the tumor microenvironment
- (2022) Ya Han et al. NUCLEIC ACIDS RESEARCH
- Circulating Exosomal PD-L1 at Initial Diagnosis Predicts Outcome and Survival of Patients with Osteosarcoma
- (2022) Jun Wang et al. CLINICAL CANCER RESEARCH
- The Role of Tumor Microenvironment in Regulating the Plasticity of Osteosarcoma Cells
- (2022) Boren Tian et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The oncogenic JAG1 intracellular domain is a transcriptional cofactor that acts in concert with DDX17/SMAD3/TGIF2
- (2022) Eun-Jung Kim et al. Cell Reports
- TGF‑β inhibitor RepSox suppresses osteosarcoma via the JNK/Smad3 signaling pathway
- (2021) Dengwei He et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- KAT6A Acetylation of SMAD3 Regulates Myeloid‐Derived Suppressor Cell Recruitment, Metastasis, and Immunotherapy in Triple‐Negative Breast Cancer
- (2021) Bo Yu et al. Advanced Science
- Involvement of the TGF-β Signaling Pathway in the Development of YAP-Driven Osteosarcoma Lung Metastasis
- (2021) Sarah Morice et al. Frontiers in Oncology
- Targeting Molecular Mechanisms Underlying Treatment Efficacy and Resistance in Osteosarcoma: A Review of Current and Future Strategies
- (2020) Ingrid Lilienthal et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- miR-16-5p Suppresses Progression and Invasion of Osteosarcoma via Targeting at Smad3
- (2020) Zhijian Gu et al. Frontiers in Pharmacology
- Glaucocalyxin A reverses EMT and TGF-β1-induced EMT by inhibiting TGF-β1/Smad2/3 signaling pathway in osteosarcoma
- (2019) Xiubo Jiang et al. CHEMICO-BIOLOGICAL INTERACTIONS
- Oridonin prevents epithelial-mesenchymal transition and TGF-β1-induced epithelial-mesenchymal transition by inhibiting TGF-β1/Smad2/3 in osteosarcoma
- (2018) Yang Sun et al. CHEMICO-BIOLOGICAL INTERACTIONS
- Profilin-1 deficiency leads to SMAD3 upregulation and impaired 3D outgrowth of breast cancer cells
- (2018) Souvik Chakraborty et al. BRITISH JOURNAL OF CANCER
- Combination cancer immunotherapies tailored to the tumour microenvironment
- (2015) Mark J. Smyth et al. Nature Reviews Clinical Oncology
- The prognostic significance of Smad3, Smad4, Smad3 phosphoisoform expression in esophageal squamous cell carcinoma
- (2014) Soo Youn Cho et al. MEDICAL ONCOLOGY
- Smad2 and Smad3 have opposing roles in breast cancer bone metastasis by differentially affecting tumor angiogenesis
- (2009) M Petersen et al. ONCOGENE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now